Endocrine Gland Neoplasms  >>  glufosfamide (D 19575)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
glufosfamide (D 19575) / Eleison Pharma
NCT00005053: Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer

Completed
2
35
Europe, RoW
glufosfamide
European Organisation for Research and Treatment of Cancer - EORTC
Pancreatic Cancer
03/01
 
NCT00442598: Safety and Efficacy Study of Glufosfamide in Ovarian Cancer

Terminated
2
17
US
Glufosfamide
Eleison Pharmaceuticals LLC.
Ovarian Cancer
04/08
04/08
NCT00102752: Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer

Completed
1/2
47
US, RoW
Glufosfamide, Gemcitabine
Threshold Pharmaceuticals, PPD
Neoplasms, Pancreatic Neoplasms
07/07
07/07

Download Options